- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07569523
Development of Preterm Infants Born During the COVID-19 Pandemic
Estudio Del Desarrollo de Los niños Prematuros Nacidos Durante la Pandemia Por el COVID-19
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Preterm babies (<34 weeks of gestation) born between March 2020 and December 2021 for case group).
- Preterm babies (<34 weeks of gestation) born between January 2023 to December 2024 (control group).
- Babies who were admitted to the NICU of the Hospital de Sant Pau.
- Babies who were followed up in External Consultations of the same hospital at least until their first year of age.
Exclusion Criteria:
- Preterm infants ≥34 weeks or preterm born outside the periods described in the inclusion criteria.
- Concurrent diagnosis of genetic pathology or major malformations.
- Families who discontinued follow-up or did not attend scheduled appointments.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Preterm babies born during the COVID-19 pandemic (2020-21)
|
Comparative and longitudinal study of development
|
|
Preterm babies born after the COVID-19 pandemic (2023-24)
|
Comparative and longitudinal study of development
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bayley Scales Of Infant and Toddler Development
Time Frame: All scores on this scale will be collected at the following ages for every child: - 3 months - 6 months - 12 months - 18 months - 24 months
|
It aims to evaluate the child's level of development in different areas. Through structured tasks and materials but in a playful format, it allows to obtain a global score of cognitive, motor and language development. From the direct scores of the scale, it is possible to obtain scalar, composite and percentile scores. The scaled scores are calculated from the direct scores of each test. They have an average of 10 and a standard deviation of 3. They represent the child's performance in relation to children of his same age. The composite scores are typical scores obtained from scales with a mean of 100 and a standard deviation of 15. From these, the corresponding percentiles can be obtained in the tables included in the manual. |
All scores on this scale will be collected at the following ages for every child: - 3 months - 6 months - 12 months - 18 months - 24 months
|
|
Wechsler Preschool and Primary Scale of Intelligence
Time Frame: All scores on this scale will be collected at the following ages for every child: - 3 years old - 5 years old
|
It allows a complete measurement of the subject's cognitive abilities.
Through structured tasks, standardized scores are obtained for the overall cognitive capacity, as well as for the verbal, manipulative, processing speed and general language indices.
In this study we will collect typical scores, composites and percentiles of each of the subtests and indexes of the Scale.
For this, based on the direct scores of each subtest, the typical scores are obtained whose mean is 10 and standard deviation 3.
These scores allow inter-individual comparison.
On the other hand, with several subtests the composite scores are formed, which correspond to the indices of the WPPSI-III (Verbal CI, Manipulative CI, Processing Speed, General Language and Total CI).
The composite scores are converted to a scale of mean 100 and standard deviation of 15.
In addition, the WPPSI-III offers percentiles for the scores of the subtests and for the indices.
|
All scores on this scale will be collected at the following ages for every child: - 3 years old - 5 years old
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIBSP-NPN-2025-20
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID - 19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States
Clinical Trials on Evaluation of cognitive and psychomotor development through the Bayley Scales Of Infant and Toddler Development and Wechsler Preschool and Primary Scale of Intelligence
-
Giancarlo NatalucciActive, not recruiting
-
Etablissement Public de Santé Barthélemy DurandNot yet recruitingChild Development | Psychomotor Performance | CultureFrance
-
Montefiore Medical CenterCompletedNeurodevelopmental Disorders | Neonatal HypoglycemiaUnited States
-
University Hospital, BrestRecruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingAnesthesia | Infant Development | Anesthesia; Adverse EffectNetherlands
-
Emory UniversityNational Institute of Neurological Disorders and Stroke (NINDS)CompletedEpilepsy | Cognition Disorders | SeizureUnited States, United Kingdom
-
University Hospital, ToulouseCompleted
-
Noordwest ZiekenhuisgroepActive, not recruitingPreterm Birth | Developmental Delay | Growth DelayNetherlands
-
University Medical Centre LjubljanaThe University of New South Wales; University of Ljubljana School of Medicine... and other collaboratorsRecruitingCTNNB1 Neurodevelopmental SyndromeSlovenia, Australia
-
Assiut UniversityCompletedEpilepsy | Attention-Deficit Hyperactivity DisorderEgypt